ANDA Litigation Settlements - Spring 2021

Published date22 April 2021
Subject MatterFDA,Patents,Life Sciences,Hatch-Waxman,Prescription Drugs,Generic Drugs,Patent-in-Suit,Patent Litigation,Pharmaceutical Patents,Patent Infringement,FDA Approval,Intellectual Property Protection,Pharmaceutical Industry,Abbreviated New Drug Application (ANDA)
AuthorJeffrey Alan Hovden,Oren Langer,Christopher Pinahs,Kelsey McElveen,Haroon Mian
Law FirmRobins Kaplan LLP

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT